Interaction between CD14 and LXRβ genes modulates Alzheimer's disease risk

Journal of the Neurological Sciences

Volumn 264, Issue 1-2, 2008, Pages 97-99

  Rodríguez Rodríguez, Eloy ^a   Sánchez Juan, Pascual ^a   Mateo, Ignacio ^a   Infante, Jon ^a   Sánchez Quintana, Coro ^a   García Gorostiaga, Inés ^a   Berciano, José ^a   Combarros, Onofre ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Alzheimer's disease; CD14; Genetic polymorphism; Lipopolysaccharide receptor; Liver X receptor

Indexed keywords

CD14 RECEPTOR; LIPOPOLYSACCHARIDE; LXR BETA RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG; CD14 ANTIGEN; CELL RECEPTOR; DNA BINDING PROTEIN; LIVER X RECEPTOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BACTERIAL INFECTION; CASE CONTROL STUDY; CELL ACTIVATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INNATE IMMUNITY; INTRON; MAJOR CLINICAL STUDY; MALE; MICROGLIA; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK ASSESSMENT; BRAIN; ENCEPHALITIS; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GLIOSIS; IMMUNOLOGICAL MONITORING; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIGENS, CD14; BRAIN; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; ENCEPHALITIS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; GLIOSIS; HUMANS; IMMUNITY, NATURAL; INTRONS; MALE; MICROGLIA; MIDDLE AGED; MONITORING, IMMUNOLOGIC; POLYMORPHISM, GENETIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 36549077619     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.08.001     Document Type: Article

References (13)

1. Wyss-Coray T., and Mucke L. Inflammation in neurodegenerative disease: a double-edged sword. Neuron 35 (2002) 419-432
2. Nguyen M.D., Julien J.P., and Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration?. Nat Rev Neurosci 3 (2002) 216-227
3. Liu Y., Walter S., Stagi M., Cherny D., Letiembre M., Schulz-Schaeffer W., et al. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain 128 (2005) 1778-1789
4. Joseph S.B., Castrillo A., Laffitte B.A., Mangelsdorf D.J., and Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9 (2003) 213-219
5. Zelcer N., and Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116 (2006) 607-614
6. Zhang-Gandhi C.X., and Drew P.D. Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes. J Neuroimmunol 183 (2007) 50-59
7. McKhaan G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 934-944
8. Combarros O., Infante J., Rodríguez E., Llorca J., Peña N., Fernández-Viadero C., et al. CD14 receptor polymorphism and Alzheimer's disease risk. Neurosci Lett 380 (2005) 193-196
9. Fassbender K., Walter S., Kuhl S., Landmann R., Ishii K., Bertsch T., et al. The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J 18 (2004) 203-205
10. Hubacek J.A., Pit'ha J., Skodová Z., Stanek V., and Poledne R. C(- 260) → T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99 (1999) 3218-3220
11. Koenig W., Khuseyinova N., Hoffmann M.M., März W., Fröhlich M., Hoffmeister A., et al. CD14 C(- 260) → T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J Am Coll Cardiol 40 (2002) 34-42
12. Minoretti P., Gazzaruso C., Di Vito C., Emanuele E., Bianchi M., Coen E., et al. Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci Lett 391 (2006) 147-149
13. Adighibe O., Arepalli S., Duckworth J., Hardy J., and Wavrant-De Vrieze F. Genetic variability at the LXR gene (NR1H2) may contribute to the risk of Alzheimer's disease. Neurobiol Aging 27 (2006) 1431-1434